What is the price target for ALS stock?
28 analysts have analysed ALS.DE and the average price target is 207.79 EUR. This implies a price increase of 16.21% is expected in the next year compared to the current price of 178.8.
FRA:ALS • US0200021014
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALLSTATE CORP (ALS.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-08-06 | Barclays | Maintains | Overweight |
| 2021-07-09 | UBS | Maintains | Neutral |
| 2021-07-09 | Wells Fargo | Maintains | Equal-Weight |
| 2021-06-28 | Barclays | Maintains | Overweight |
| 2021-06-21 | Citigroup | Maintains | Neutral |
| 2021-06-03 | Piper Sandler | Maintains | Overweight |
| 2021-06-03 | Citigroup | Downgrade | Buy -> Neutral |
| 2021-05-27 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-05-10 | Raymond James | Maintains | Strong Buy |
| 2021-05-06 | JP Morgan | Maintains | Overweight |
| 2021-04-19 | Raymond James | Maintains | Strong Buy |
| 2021-04-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-12 | JP Morgan | Maintains | Overweight |
| 2021-03-30 | Raymond James | Maintains | Strong Buy |
| 2021-03-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 57.094B 11.05% | 64.106B 12.28% | 67.685B 5.58% | 63.32B -6.45% | 67.052B 5.89% | 72.723B 8.46% | 78.439B 7.86% | |
| EBITDA YoY % growth | 904M 244.64% | 6.777B 649.67% | 12.495B 84.37% | 9.473B -24.19% | 8.947B -5.55% | 8.896B -0.57% | N/A | |
| EBIT YoY % growth | 200M 113.59% | 6.222B 3,011.00% | 12.013B 93.07% | 7.914B -34.12% | 7.602B -3.94% | 8.664B 13.97% | N/A | |
| Operating Margin | 0.35% | 9.71% | 17.75% | 12.50% | 11.34% | 11.91% | N/A | |
| EPS YoY % growth | 0.91 182.73% | 18.32 1,913.19% | 34.95 90.78% | 25.49 -27.08% | 25.47 -0.07% | 25.47 -0.01% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.19 103.55% | 4.40 -25.89% | 5.31 -52.45% | 7.82 -45.37% | 7.02 -2.37% | 3.89 -11.62% | 5.40 1.75% | 8.22 5.15% | 7.57 7.91% | 3.83 -1.51% | 6.18 14.39% |
| Revenue Q2Q % growth | 15.299B -7.01% | 16.142B 7.28% | 16.802B 7.50% | 15.693B 7.69% | 16.209B 5.95% | 17.215B 6.65% | 17.941B 6.78% | 16.73B 6.61% | 16.759B 3.39% | 17.842B 3.64% | 18.601B 3.68% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 2.202B 163.71% | 1.312B -31.95% | 1.531B -63.69% | 1.976B -60.74% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
28 analysts have analysed ALS.DE and the average price target is 207.79 EUR. This implies a price increase of 16.21% is expected in the next year compared to the current price of 178.8.
ALLSTATE CORP (ALS.DE) will report earnings on 2026-04-29, after the market close.
The consensus EPS estimate for the next earnings of ALLSTATE CORP (ALS.DE) is 7.19 EUR and the consensus revenue estimate is 15.30B EUR.
The number of analysts covering ALLSTATE CORP (ALS.DE) is 28.